Phibro Animal Health | PAHC - Capital De Empréstimo





Capital De Empréstimo Alterar Data
Align Technology USD 0 0 2024-12
ANI Pharmaceuticals USD 286M 5.84M 2026-03
Aurora Cannabis CAD 18.13M 15.07M 2026-03
Bristol-Myers Squibb USD 42.09B 59M 2026-06
Canopy Growth CAD 217.12M 7.87M 2026-03
Eli Lilly USD 39.37B 1.5B 2026-03
Henry Schein USD 2.33B 17M 2026-03
Idexx Laboratories USD 299.85M 74.99M 2026-03
Knight Therapeutics CAD 57.78M 26.92M 2025-12
Merck USD 46.67B 77M 2026-03
Nektar Therapeutics USD 63.16M 44.35M 2025-12
Pacira USD 367.66M 4.53M 2026-03
Phibro Animal Health USD 597.68M 5.92M 2026-03
Prestige Brands USD 1.01B 40.28M 2026-03
Supernus Pharmaceuticals USD 400.38M 21.13M 2022-03
Zoetis USD 9.04B 3M 2026-03